Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2025 -3.113M
December 31, 2024 -3.488M
June 30, 2024 -2.878M
December 31, 2023 -3.592M
June 30, 2023 -4.876M
December 31, 2022 -5.866M
June 30, 2022 -6.835M
December 31, 2021 -6.451M
June 30, 2021 -6.421M
December 31, 2020 -5.864M
June 30, 2020 -4.641M
December 31, 2019 -3.592M
June 30, 2019 -2.384M
December 31, 2018 -1.979M
June 30, 2018 -2.034M
December 31, 2017 -1.691M
June 30, 2017 -1.207M
December 31, 2016 -0.6155M
June 30, 2016 -0.2415M
December 31, 2015 -0.2393M
June 30, 2015 -0.2439M
December 31, 2014 -0.2592M
Date Value
June 30, 2014 -0.2535M
December 31, 2013 -0.179M
June 30, 2013 -0.2684M
December 31, 2012 -0.7413M
June 30, 2012 -0.5909M
December 31, 2011 -0.1642M
June 30, 2011 0.0871M
December 31, 2010 -0.0014M
June 30, 2010 -1.033M
December 31, 2009 -1.553M
June 30, 2009 -1.144M
December 31, 2008 -4.273M
June 30, 2008 -2.154M
December 31, 2007 -3.133M
June 30, 2007 -11.57M
December 31, 2006 -11.18M
June 30, 2006 -5.276M
December 31, 2005 -2.002M
June 30, 2005 -1.982M
December 31, 2004 -1.922M
June 30, 2004 -1.965M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Percheron Therapeutics Ltd. -3.485M
Starpharma Holdings Ltd. -2.255M
Neuren Pharmaceuticals Ltd. 6.411M
Mayne Pharma Group Ltd. 10.97M
Acrux Ltd. 0.7159M